22 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Altra ricerca

CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer's disease spectrum.

Mubarak Alruwaili, Areej Ahmed Turkistani, Sireen Abdul Rahim Shilbayeh, Dahlia Soleman A Mirdad, Marwa Fareed Almulhim, Saud Alnaaim, Muhannad Almubarak, Alzheimer’s Disease Neuroimaging Initiative

Immunologic research · 2026

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansAlzheimer DiseaseAmyloid beta-PeptidesBiomarkersFemaleMaleCognitive Dysfunctiontau ProteinsAgedPeptide FragmentsGlial Fibrillary Acidic ProteinAged, 80 and overReceptors, ImmunologicADAM17 ProteinMembrane GlycoproteinsNeuroinflammatory DiseasesReceptors, Tumor Necrosis Factor, Type IIAlzheimer’s diseaseCSF biomarkersCognitive impairmentNeuroinflammationNeuroinflammatory biomarkers

Come citare questo studio

Mubarak Alruwaili, Areej Ahmed Turkistani, Sireen Abdul Rahim Shilbayeh, Dahlia Soleman A Mirdad, Marwa Fareed Almulhim, Saud Alnaaim, Muhannad Almubarak, Alzheimer’s Disease Neuroimaging Initiative. (2026). CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer's disease spectrum.. Immunologic research. DOI: 10.1007/s12026-026-09848-1

Consulta la pubblicazione originale ↗